U.S. President Donald Trump meets with United Nations Secretary-General Antonio Guterres (not pictured) during the 80th United Nations General Assembly, in New York City, New York, U.S., September 23, ...
The FDA approved imlunestrant for treatment of certain adults with breast cancer who experience disease progression after at least one prior line of endocrine therapy.
Historical Data is currently not available. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback